Tag: HealthEquity
-
Lupin Gains USFDA Approval for Generic HIV Medication
Lupin has received tentative approval from the USFDA for its generic version of the HIV drug Triumeq PD, combining Abacavir, Dolutegravir, and Lamivudine. This approval paves the way for more affordable HIV treatment options, particularly in underserved regions, enhancing access to life-saving care.
Recent Posts
- Bajaj Finance Approves Authorised Share Capital Upgrade to Rs 1,000 Crore
- Patel Engineering Secures Humongous Infrastructure Contracts of ₹2,036.89 Crore in Maharashtra and Arunachal Pradesh
- HUDCO Board Clears ₹2,430 Crore NCD Issue: What it Means to the Market and Investors
- HCL Tech Q4 Profit Rises 8.1% to Rs 4,307 Crore: Consistent Growth on the Back of Large Deals
- HG Infra Bags 300 MW/600 MWh Battery Energy Storage System Project from Gujarat Urja Vikas Nigam